Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Scientific Data
|
January 31, 2024
Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis
Hamza Khan, Lotte Geys, Peer Baneke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application
Jennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosis
Joanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 25, 2012
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS
Robert J Fox, Alan Thompson, David Baker, et al.
Multiple Sclerosis and Related Disorders
|
April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
Paola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Frontiers in Neurology
|
July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event
Paola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
Nature Reviews. Neurology
|
May 19, 2023
Global synergistic actions to improve brain health for human development
Mayowa O Owolabi, Matilde Leonardi, Claudio Bassetti, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Scientific Data
|
January 31, 2024
Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis
Hamza Khan, Lotte Geys, Peer Baneke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application
Jennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosis
Joanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton, Rachel King, Lindsay Rechtman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 25, 2012
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS
Robert J Fox, Alan Thompson, David Baker, et al.
Multiple Sclerosis and Related Disorders
|
April 3, 2022
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
Paola Zaratin, Patrick Vermersch, Maria Pia Amato, et al.
Frontiers in Neurology
|
July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event
Paola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
Nature Reviews. Neurology
|
May 19, 2023
Global synergistic actions to improve brain health for human development
Mayowa O Owolabi, Matilde Leonardi, Claudio Bassetti, et al.
Page
of 1